Oak Hill Capital Announces Formation of Petauri Health
NEW YORK, Feb. 1, 2023 /PRNewswire/ -- Oak Hill Capital, a New York-based middle-market private equity firm, announced today that it has partnered with Dan Renick to launch Petauri Health ("Petauri" or "the Company"), a purpose-built pharmaceutical commercialization services platform. Petauri Health, based in New York, New York, will seek to acquire and combine best-in-class companies with recognized expertise in global market access, medical affairs, patient services, and data and analytics. The resulting Petauri platform will strive to seamlessly support clients with data-driven, digital-forward solutions that speed patient access to life-changing care. Oak Hill aims to deploy in excess of $250 million of equity capital from its latest fund (OHCP VI) behind this initiative over time.
- Oak Hill Capital and life sciences industry leader Dan Renick team up to create new organization offering integrated commercialization solutions.
- NEW YORK, Feb. 1, 2023 /PRNewswire/ -- Oak Hill Capital, a New York-based middle-market private equity firm, announced today that it has partnered with Dan Renick to launch Petauri Health ("Petauri" or "the Company"), a purpose-built pharmaceutical commercialization services platform.
- Oak Hill aims to deploy in excess of $250 million of equity capital from its latest fund (OHCP VI) behind this initiative over time.
- Brian Cherry, Managing Partner at Oak Hill Capital, added, "Our formation of Petauri Health with Dan is an excellent example of Oak Hill's theme-based and systematic approach to investing.